Corrigendum to “Patients With Severe Aortic Valve Stenosis and Impaired Platelet Function Benefit From Preoperative Desmopressin Infusion” [Ann Thorac Surg 91(5) (2011) 1420-1426](S0003497511002414)(10.1016/j.athoracsur.2011.01.052);Patients with severe aortic valve stenosis and impaired platelet function benefit from preoperative desmopressin infusion

Annals of Thoracic Surgery

Volumn 91, Issue 5, 2011, Pages 1420-1426

  Steinlechner, Barbara ^a   Zeidler, Petra ^a   Base, Eva ^a   Birkenberg, Beatrice ^a   Ankersmit, Hendrik Jan ^a   Spannagl, Michael ^a   Quehenberger, Peter ^a   Hiesmayr, Michael ^a   Jilma, Bernd ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN BINDING PROTEIN; DESMOPRESSIN; VON WILLEBRAND FACTOR;

AGED; ANESTHESIA INDUCTION; AORTA VALVE REPLACEMENT; AORTA VALVE STENOSIS; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MOLECULAR WEIGHT; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCREENING; THROMBOCYTE DYSFUNCTION;

EID: 79955375429     PISSN: 00034975     EISSN: 15526259     Source Type: Journal    
DOI: 10.1016/j.athoracsur.2019.12.001     Document Type: Erratum

References (35)

1. A. Vincentelli, S. Susen, and T. Le Tourneau Acquired von Willebrand syndrome in aortic stenosis N Engl J Med 349 2003 343 349 (Pubitemid 36886240)
2. C. Velik-Salchner, S. Eschertzhuber, W. Streif, H. Hangler, U. Budde, and D. Fries Acquired von Willebrand syndrome in cardiac patients J Cardiothorac Vasc Anesth 22 2008 719 724
3. G.J. Despotis, V. Levine, R. Saleem, E. Spitznagel, and J.H. Joist Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial Lancet 354 1999 106 110 (Pubitemid 29313144)
4. E.W. Salzman, M.J. Weinstein, and R.M. Weintraub Treatment with desmopressin acetate to reduce blood loss after cardiac surgery A double-blind randomized trial N Engl J Med 314 1986 1402 1406 (Pubitemid 16114693)
5. E.J. Favaloro Clinical utility of the PFA-100 Semin Thromb Hemost 34 2008 709 733
6. P. Jilma-Stohlawetz, M.E. Gorczyca, B. Jilma, J. Siller-Matula, J.C. Gilbert, and P. Knbl Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura Thromb Haemost 105 2011 545 552
7. F.B. Mayr, P. Knbl, and B. Jilma The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo Transfusion 50 2010 1079 1087
8. A.O. Spiel, F.B. Mayr, and N. Ladani The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction Platelets 20 2009 334 340
9. S.I. Rapaport Preoperative hemostatic evaluation: which tests, if any? Blood 61 1983 229 231 (Pubitemid 13137638)
10. P. Harrison The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults Br J Haematol 130 2005 3 10 (Pubitemid 40979127)
11. C.P. Hayward, P. Harrison, and M. Cattaneo Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function J Thromb Haemost 4 2006 312 319
12. U. Derhaschnig, and B. Jilma Assessment of platelets and the endothelium in patients presenting with acute coronary syndromes-is there a future? Thromb Haemost 102 2009 1144 1148
13. U. Derhaschnig, I. Schweeger-Exeli, C. Marsik, F. Cardona, P. Minuz, and B. Jilma Effects of aspirin and NO-aspirin (NCX 4016) on platelet function and coagulation in human endotoxemia Platelets 21 2010 320 328
14. B. Jilma Platelet function analyzer (PFA-100): a tool to quantify congenital or acquired platelet dysfunction J Lab Clin Med 138 2001 152 163 (Pubitemid 32812228)
15. R.A. Reiter, K. Varadi, P.L. Turecek, B. Jilma, and P. Knbl Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation Thromb Haemost 93 2005 554 558 (Pubitemid 40392546)
16. J.L. Francis Platelet dysfunction detected at high shear in patients with heart valve disease Platelets 11 2000 133 136 (Pubitemid 30345420)
17. M. Schleef, E. Strobel, A. Dick, J. Frank, W. Schramm, and M. Spannagl Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals Br J Haematol 128 2005 100 107
18. B. Jilma, P. Paulinska, P. Jilma-Stohlawetz, J.C. Gilbert, R. Hutabarat, and P. Knbl A randomised pilot trial of the anti-von Willebrand factor aptamer ARC1779 in patients with type 2b von Willebrand disease Thromb Haemost 104 2010 563 570
19. C. Velik-Salchner, S. Maier, and P. Innerhofer Point-of-care whole blood impedance aggregometry versus classical light transmission aggregometry for detecting aspirin and clopidogrel: the results of a pilot study Anesth Analg 107 2008 1798 1806
20. E.I. Lev, M. Ramchandani, and R. Garg Response to aspirin and clopidogrel in patients scheduled to undergo cardiovascular surgery J Thromb Thrombolysis 24 2007 15 21 (Pubitemid 46831559)
21. H.J. Hertfelder, M. Bs, D. Weber, K. Winkler, P. Hanfland, and C.J. Preusse Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting Semin Thromb Hemost 31 2005 426 440 (Pubitemid 41362349)
22. M. Fattorutto, O. Pradier, D. Schmartz, B. Ickx, and L. Barvais Does the platelet function analyser (PFA-100) predict blood loss after cardiopulmonary bypass? Br J Anaesth 90 2003 692 693 (Pubitemid 36592347)
23. T.F. Slaughter, G. Sreeram, A.D. Sharma, H. El-Moalem, C.J. East, and C.S. Greenberg Reversible shear-mediated platelet dysfunction during cardiac surgery as assessed by the FA-100 platelet function analyzer Blood Coagul Fibrinolysis 12 2001 85 93 (Pubitemid 32234815)
24. D. Lasne, A. Fiemeyer, G. Chatellier, C. Chammas, J.F. Baron, and M. Aiach A study of platelet functions with a new analyzer using high shear stress (PFA 100) in patients undergoing coronary artery bypass graft Thromb Haemost 84 2000 794 799
25. A.O. Spiel, J. Siller-Matula, C. Firbas, J.M. Leitner, G. Russmueller, and B. Jilma Single dose granulocyte colony-stimulating factor markedly enhances shear-dependent platelet function in humans Platelets 21 2010 464 469
26. S. Panzer, R. Badr Eslam, and A. Schneller Loss of high-molecular-weight von Willebrand factor multimers mainly affects platelet aggregation in patients with aortic stenosis Thromb Haemost 103 2010 408 414
27. A. Tiede, J. Priesack, and S. Werwitzke Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study J Thromb Haemost 6 2008 569 576 (Pubitemid 351404923)
28. B. Steinlechner, M. Dworschak, and B. Birkenberg Platelet dysfunction in outpatients with left ventricular assist devices Ann Thorac Surg 87 2009 131 137
29. C.F. Weber, W. Dietrich, M. Spannagl, C. Hofstetter, and C. Jmbor A point-of-care assessment of the effects of desmopressin on impaired platelet function using multiple electrode whole-blood aggregometry in patients after cardiac surgery Anesth Analg 110 2010 702 707
30. R.A. Reiter, F. Mayr, and H. Blazicek Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin Blood 102 2003 4594 4599 (Pubitemid 37494129)
31. H.H. van Vliet, M.C. Kappers-Klunne, F.W. Leebeek, and J.J. Michiels PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII/VWF concentrate substitution in von Willebrand disease type 1 and 2 Thromb Haemost 100 2008 462 468
32. M. Weinstein, J.A. Ware, J. Troll, and E. Salzman Changes in von Willebrand factor during cardiac surgery: effect of desmopressin acetate Blood 71 1988 1648 1655
33. G. Dilthey, W. Dietrich, M. Spannagl, and J.A. Richter Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin J Cardiothorac Vasc Anesth 7 1993 425 430 (Pubitemid 23231396)
34. E. Ozkisacik, F. Islamoglu, and H. Posacioglu Desmopressin usage in elective cardiac surgery J Cardiovasc Surg (Torino) 42 2001 741 747
35. M. Levi, M.E. Cromheecke, and E. de Jonge Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints Lancet 354 1999 1940 1947